{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:26:39Z","timestamp":1790630799440,"version":"4.1.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2018,9,2]]},"DOI":"10.1080\/21645515.2018.1445448","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T22:04:10Z","timestamp":1519682650000},"page":"2158-2162","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":77,"title":["Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine"],"prefix":"10.1080","volume":"14","author":[{"given":"Scott B.","family":"Halstead","sequence":"first","affiliation":[{"name":"Private Consultant, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506223"},{"key":"CIT0002","first-page":"421","volume":"90","author":"WHO","year":"2015","journal-title":"Weekly Epidemiological Record."},{"key":"CIT0003","first-page":"441","volume-title":"Department of Immunization VaB","author":"WHO","year":"2008"},{"key":"CIT0004","first-page":"265","volume":"91","author":"WHO","year":"2016","journal-title":"Weekly Epidemiological Record."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.070"},{"key":"CIT0006","volume-title":"Immunization VaB","author":"WHO","year":"2017"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.02.004"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-0222"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004854"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9590"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61428-7"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61060-6"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411037"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.11.023"},{"key":"CIT0015","volume-title":"Background Paper on Dengue Vaccines, SAGE Working Group on Dengue Vaccine.","author":"Secretariat","year":"2016"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(03)60011-4"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.3201\/eid0812.020170"},{"key":"CIT0018","first-page":"18","volume":"3","author":"WHO","year":"2018","journal-title":"Weekly Epidemiological Record."},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.004"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004830"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw297"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.003"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2015.2"},{"key":"CIT0024","first-page":"349","volume":"91","author":"WHO","year":"2016","journal-title":"Weekly Epidemiological Record."},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002181"},{"key":"CIT0026","unstructured":"Global Vaccine Safety Blueprint. WHO\/IVB\/12.07. WHO, Geneva, 2012. pp 38."},{"key":"CIT0027","unstructured":"Guidelines on the quality, safety and efficacy of dengue tetravalent vaccines (live, attenuated). Geneva: WHO Technical Report Series, 2011. Annex 2 2011."},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.05.058"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw340"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw341"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw458"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2018.1445448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T12:50:51Z","timestamp":1544014251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2018.1445448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,7,24]]},"published-print":{"date-parts":[[2018,9,2]]}},"alternative-id":["10.1080\/21645515.2018.1445448"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2018.1445448","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}